Who invested in DeNova

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$7.0Mraised across 1 round since 2023, from 1 source

Latest round: Grant, $7.0MApr 2023
Investors: 2

See who backed them

The rounds

Apr 2023
Grant$7.0M
- Atlantic Canada Opportunities Agency
- National Research Council of Canada Industrial Research Assistance Program
Source recorded

Founders and team

From DeNova's own website: 1 founder, 11 on the team.

Brianna Orr StrattonFounder & Chief Executive Officer

Denita McKnightChief Communications Officer
Kevin NielsenChief Financial Officer
Kurt MolnarChief Business Development Officer
Rejean TetraultChief Operations Officer
Talia BoatesChief of Staff
Dr. Niels AlstedDirector
Georg BaunachDirector
Matt StanleyDirector
Michael CrothersDirector
Rhiannon DaviesDirector
Robert OrrDirector, CHAIR

AdvisersDr. Darian Mcbain

Everyone who backed them

Atlantic Canada Opportunities AgencyVC firm1round

National Research Council of Canada Industrial Research Assistance ProgramVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about DeNova

Who invested in DeNova?

DeNova's investors include Atlantic Canada Opportunities Agency and National Research Council of Canada Industrial Research Assistance Program.

How much has DeNova raised?

DeNova has raised $7.0M across 1 round since 2023.

When did DeNova last raise?

DeNova's most recent round was a Grant of $7.0M in Apr 2023.

What was DeNova's biggest round?

Its most recent round, $7.0M in Apr 2023, is also its largest on record.

Who backed DeNova first?

DeNova's first round on record, in Apr 2023, was backed by Atlantic Canada Opportunities Agency and National Research Council of Canada Industrial Research Assistance Program.